Evidence for a catabolic role of glucagon during an amino acid load.

Despite the strong association between protein catabolic conditions and hyperglucagonemia, and enhanced glucagon secretion by amino acids (AA), glucagon's effects on protein metabolism remain less clear than on glucose metabolism. To clearly define glucagon's catabolic effect on protein metabolism during AA load, we studied the effects of glucagon on circulating AA and protein dynamics in six healthy subjects. Five protocols were performed in each subject using somatostatin to inhibit the secretion of insulin, glucagon, and growth hormone (GH) and selectively replacing these hormones in different protocols. Total AA concentration was the highest when glucagon, insulin, and GH were low. Selective increase of glucagon levels prevented this increment in AA. Addition of high levels of insulin and GH to high glucagon had no effect on total AA levels, although branched chain AA levels declined. Glucagon mostly decreased glucogenic AA and enhanced glucose production. Endogenous leucine flux, reflecting proteolysis, decreased while leucine oxidation increased in protocols where AA were infused and these changes were unaffected by the hormones. Nonoxidative leucine flux reflecting protein synthesis was stimulated by AA, but high glucagon attenuated this effect. Addition of GH and insulin partially reversed the inhibitory effect of glucagon on protein synthesis. We conclude that glucagon is the pivotal hormone in amino acid disposal during an AA load and, by reducing the availability of AA, glucagon inhibits protein synthesis stimulated by AA. These data provide further support for a catabolic role of glucagon at physiological concentrations.

[1]  T. Claus,et al.  Glucagon and Gluconeogenesis , 1983 .

[2]  E. Roth,et al.  Free amino acid levels in muscle and liver of a patient with glucagonoma syndrome. , 1987, Metabolism: clinical and experimental.

[3]  F. Moore,et al.  Hormone-substrate interrelationships following trauma. , 1974, Archives of surgery.

[4]  J. Shull,et al.  Hormonal regulation of amino acid transport and cAMP production in monolayer cultures of rat hepatocytes , 1980, Journal of cellular physiology.

[5]  S. Bloom,et al.  Hyperglucagonaemia in the surgical patient. , 1975, British medical journal.

[6]  M. Marre,et al.  The Amino Acid-Induced Secretion of Glucagon , 1983 .

[7]  J. Callés-Escandon,et al.  Insulin dissociates hepatic glucose cycling and glucagon-induced thermogenesis in man. , 1994, Metabolism: clinical and experimental.

[8]  Del,et al.  Differential effects of hyperinsulinemia and hyperaminoacidemia on leucine-carbon metabolism in vivo. Evidence for distinct mechanisms in regulation of net amino acid deposition. , 1987, The Journal of clinical investigation.

[9]  S. Kalhan,et al.  In vivo differences between the turnover rates of leucine and leucine's ketoacid in stable cirrhosis. , 1992, Gastroenterology.

[10]  O. Owen,et al.  Effects of glucagon on plasma amino acids. , 1984, The Journal of clinical investigation.

[11]  K. Nair,et al.  Hyperglucagonemia increases resting metabolic rate in man during insulin deficiency. , 1987, The Journal of clinical endocrinology and metabolism.

[12]  D. Matthews,et al.  Measurement of leucine metabolism in man from a primed, continuous infusion of L-[1-3C]leucine. , 1980, The American journal of physiology.

[13]  K. Polonsky,et al.  Hepatic metabolism of glucagon in the dog: contribution of the liver to overall metabolic disposal of glucagon. , 1981, The American journal of physiology.

[14]  W. Ward,et al.  Effects of glucagon on general protein degradation and synthesis in perfused rat liver. , 1974, The Journal of biological chemistry.

[15]  D. Halliday,et al.  Mass spectrometric assay of stable isotopic enrichment for the estimation of protein turnover in man , 1981, Proceedings of the Nutrition Society.

[16]  D. J. Millward,et al.  Regulation of leucine metabolism in man: a stable isotope study. , 1981, Science.

[17]  P. Flakoll,et al.  The role of glucagon in the control of protein and amino acid metabolism in vivo. , 1994, Metabolism: clinical and experimental.

[18]  R. Wolfe,et al.  Bradykinin attenuates glucagon-induced leucine oxidation in humans. , 1990, The American journal of physiology.

[19]  B. Beaufrère,et al.  Use of reciprocal pool specific activities to model leucine metabolism in humans. , 1985, The American journal of physiology.

[20]  D. Matthews,et al.  Plasma amino acid kinetics during acute states of glucagon deficiency and excess in healthy adults. , 1990, The American journal of physiology.

[21]  K. Nair,et al.  Acute growth hormone effects on amino acid and lipid metabolism. , 1994, The Journal of clinical endocrinology and metabolism.

[22]  F. H. Walters,et al.  High performance liquid chromatographic determination of amino acids in the picomole range. , 1979, Analytical chemistry.

[23]  A. Le Cam,et al.  Insulin and glucagon stimulation of amino acid transport in isolated rat hepatocytes. Synthesis of a high affinity component of transport. , 1979, The Journal of biological chemistry.

[24]  E. Nadel,et al.  Isotopic analysis of leucine and urea metabolism in exercising humans. , 1982, Journal of applied physiology: respiratory, environmental and exercise physiology.

[25]  E. Barrett,et al.  Effect of infused branched-chain amino acids on muscle and whole-body amino acid metabolism in man. , 1990, Clinical science.

[26]  C. Park,et al.  Control of gluconeogenesis from amino acids in the perfused rat liver. , 1969, The Journal of biological chemistry.

[27]  R. DeFronzo,et al.  Leucine Metabolism in IDDM: Role of Insulin and Substrate Availability , 1990, Diabetes.

[28]  E. Rayfield,et al.  Transhepatic glucagon gradients in man: evidence for glucagon extraction by human liver. , 1984, The Journal of clinical endocrinology and metabolism.

[29]  M. Buse,et al.  Effects of branched-chain amino acids on protein turnover. , 1989, Diabetes/metabolism reviews.

[30]  R. DeFronzo,et al.  Effect of insulin and plasma amino acid concentrations on leucine metabolism in man. Role of substrate availability on estimates of whole body protein synthesis. , 1987, The Journal of clinical investigation.

[31]  T. Jenssen,et al.  Failure of substrate-induced gluconeogenesis to increase overall glucose appearance in normal humans. Demonstration of hepatic autoregulation without a change in plasma glucose concentration. , 1990, The Journal of clinical investigation.

[32]  D. Kipnis,et al.  In-vivo Measurement of Glucose and Alanine Metabolism with Stable Isotopic Tracers , 1977, Diabetes.

[33]  R. Hoeldtke,et al.  Role of glucagon in disposal of an amino acid load. , 1990, The American journal of physiology.

[34]  R. Unger,et al.  The role of aminogenic glucagon secretion in blood glucose homeostasis. , 1969, The Journal of clinical investigation.

[35]  F. A. Kenney,et al.  Heated dorsal hand vein sampling for metabolic studies: a reappraisal. , 1992, The American journal of physiology.

[36]  D. Matthews,et al.  Insulin-mediated reduction of whole body protein breakdown. Dose-response effects on leucine metabolism in postabsorptive men. , 1985, The Journal of clinical investigation.

[37]  P. Flakoll,et al.  Amino acids augment insulin's suppression of whole body proteolysis. , 1989, The American journal of physiology.

[38]  D. M. Rocha,et al.  Abnormal pancreatic alpha-cell function in bacterial infections. , 1973, The New England journal of medicine.

[39]  M. Buse,et al.  Activation of rat liver branched-chain 2-oxo acid dehydrogenase in vivo by glucagon and adrenaline. , 1985, The Biochemical journal.

[40]  S. Bloom,et al.  A glucagonoma syndrome. , 1974, Lancet.

[41]  S. V. Silva,et al.  The control of protein degradation in monolayer cultures of cat hepatocytes. , 1992, The International journal of biochemistry.

[42]  Douglas W. Wilmore,et al.  HYPERGLUCAGONÆMIA AFTER BURNS , 1974 .

[43]  K. Nair,et al.  Leucine as a regulator of whole body and skeletal muscle protein metabolism in humans. , 1992, The American journal of physiology.

[44]  K. Nair,et al.  Protein dynamics in whole body and in splanchnic and leg tissues in type I diabetic patients. , 1995, The Journal of clinical investigation.

[45]  W. Blackard,et al.  Portal and Peripheral Vein Immunoreactive Glucagon Concentrations After Arginine or Glucose Infusions , 1974, Diabetes.

[46]  K. Nair,et al.  Hyperglucagonemia during insulin deficiency accelerates protein catabolism. , 1987, The American journal of physiology.

[47]  G. Cahill Physiology of Insulin In Man: The Banting Memorial Lecture 1971 , 1971, Diabetes.

[48]  B. Lardeux,et al.  Mechanism and regulation of protein degradation in liver. , 1989, Diabetes/metabolism reviews.

[49]  N. Abumrad,et al.  Use of a heated superficial hand vein as an alternative site for the measurement of amino acid concentrations and for the study of glucose and alanine kinetics in man. , 1981, Metabolism: clinical and experimental.

[50]  O. Owen,et al.  Glucagon deficiency and hyperaminoacidemia after total pancreatectomy. , 1980, The Journal of clinical investigation.

[51]  E. N. Bergman,et al.  Effect of glucagon on plasma alanine and glutamine metabolism and hepatic gluconeogenesis in sheep. , 1975, The American journal of physiology.

[52]  K. Nair,et al.  Relationship of resting metabolic rate to body composition and protein turnover. , 1990, The American journal of physiology.

[53]  K. Nair,et al.  Effect of leucine on amino acid and glucose metabolism in humans. , 1992, Metabolism: clinical and experimental.